Abstracts tagged "platelets and vasculitis"

Abstract Number: 798 • 2017 ACR/ARHP Annual Meeting
Altered Phenotype of Platelets and Neutrophils Toward Neutrophil-Platelet Interaction in Circulation of Small and Large Vessel Vasuculitis
Kotaro Matsumoto¹, Hidekata Yasuoka², Komei Sakata¹, Keiko Yoshimoto^1,3, Katsuya Suzuki^1,4, Kunihiro Yamaoka¹ and Tsutomu Takeuchi¹, ¹Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ²35 Shinanomachi, Shinjuku, Keio University School of Medicine, Tokyo, Japan, ³Keio University School of Medicine, Clinical and Translational Research Center, Tokyo, Japan, ⁴Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan
Background/Purpose: Neutrophils play an important role in the pathogenesis of necrotizing vasculitis, and activation of neutrophil is one of important triggers of the disease process.…
Abstract Number: 1537 • 2012 ACR/ARHP Annual Meeting
Pathogenesis of Atherosclerosis in Granulomatosis Polyangiitis
Rula Hajj-Ali¹, Roy L. Silverstein², Gary S. Hoffman³ and Carol A. Langford⁴, ¹Cleveland Clinic Foundation, Cleveland, OH, ²Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI, ³Rheumatic & Immunologic Dis, Cleveland Clinic Found A50, Cleveland, OH, ⁴Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH
Background/Purpose: Previous studies from our group suggested that the inflammatory events that occur during relapses in patients with Granulomatosis with Polyangiitis (GPA, Wegener’s) may have…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].